Translational neurosciences and clinical development expert joins leading neuroplasticity company BOSTON, June 12, 2023 /PRNewswire/ — Delix Therapeutics (the “Company”), a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological conditions, today announced the appointment of Dr. Aaron Koenig as Chief Medical Officer. Dr.
